Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD)

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 255-260

  Lehmann, H Immo ^c   Wolke, Carmen ^a   Malenke, Wiebke ^a   Röhl, Friedrich Wilhelm ^c   Hammwöhner, Matthias ^b   Bukowska, Alicja ^c   Lendeckel, Uwe ^a   Goette, Andreas ^b,c  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b St Vincenz Hospital   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

DPIV; ICD intervention; Renin angiotensin system (RAS); Risk marker for SCD

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE B; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL PEPTIDASE IV; INSULIN REGULATED AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERVENTION STUDY; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; TREATMENT INDICATION;

DPIV; ICD INTERVENTION; RENIN ANGIOTENSIN SYSTEM (RAS); RISK MARKER FOR SCD;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DIPEPTIDYL PEPTIDASE 4; ENZYME ACTIVATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84883799286     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.083     Document Type: Article

References (41)

1. A.J. Moss, W.J. Hall, and D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
2. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
3. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
5. T. Chow, D.J. Kereiakes, and J. Onufer Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial J Am Coll Cardiol 52 2008 1607 1615
6. R. Dhar, A.A. Alsheikh-Ali, and N.A.M. Estes Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) Heart Rhythm 5 2008 807 813
7. J.P. Daubert, W. Zareba, and W.J. Hall Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients J Am Coll Cardiol 47 2006 98 107
8. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
9. P.E. Ward, I.F. Benter, L. Dick, and S. Wilk Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M Biochem Pharmacol 40 1990 1725 1732
10. A.L. Albiston, S.G. McDowall, and D. Matsacos Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase J Biol Chem 276 2001 48623 48626
11. S. Epelman, K. Shrestha, and R.W. Troughton Soluble angiotensin- converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes J Card Fail 15 2009 565 571
12. M. Vanderheyden, C. Vrints, S. Verstreken, J. Bartunek, J. Beunk, and M. Goethals B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications Biomark Med 4 2010 315 320
13. I. Brandt, A.M. Lambeir, J.M. Ketelslegers, M. Vanderheyden, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin Chem 52 2006 82 87
14. G. Vanhoof, I. De Meester, and D. Hendriks Proline-specific aminopeptidases: potential role in bradykinin degradation Agents Actions Suppl 38 Pt 2 1992 120 127
15. J.B. Pesquero, G.N. Jubilut, C.J. Lindsey, and A.C. Paiva Bradykinin metabolism pathway in the rat pulmonary circulation J Hypertens 10 1992 1471 1478
16. J.P. Singh, W.J. Hall, and S. McNitt Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) J Am Coll Cardiol 46 2005 1712 1720
17. H.I. Lehmann, A. Goette, and J. Martens-Lobenhoffer Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction Europace 13 2011 1428 1435
18. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 2006 e247 e346
19. H. Chen, B.P. Roques, and M.C. Fournié-Zaluski Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor Bioorg Med Chem Lett 9 1999 1511 1516
20. K.H. Haugaa, T. Edvardsen, and J.P. Amlie Prediction of life-threatening arrhythmias - still an unresolved problem Cardiology 118 2011 129 137
21. S. Okutucu, and A. Oto Risk stratification in nonischemic dilated cardiomyopathy: current perspectives Cardiol J 17 2010 219 229
22. R. Bechtloff, A. Goette, and A. Bukowska Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease Int J Cardiol 146 2011 164 170
23. J.W. Wright, and J.W. Harding Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions Regul Pept 59 1995 269 295
24. R.A. Santos, A.C. Simoes e Silva, and C. Maric Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc Natl Acad Sci U S A 100 2003 8258 8263
25. G.I. Rice, D.A. Thomas, P.J. Grant, A.J. Turner, and N.M. Hooper Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism Biochem J 383 2004 45 51
26. J.L. Grobe, A.P. Mecca, and M. Lingis Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) Am J Physiol Heart Circ Physiol 292 2007 H736 H742
27. A.E. Loot, A.J. Roks, and R.H. Henning Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats Circulation 105 2002 1548 1550
28. I. Porsti, A.T. Bara, R. Busse, and M. Hecker Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor Br J Pharmacol 111 1994 652 654
29. K.B. Brosnihan, P. Li, and C.M. Ferrario Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide Hypertension 27 1996 523 528
30. K. Yamamoto, M. Ohishi, and T. Katsuya Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II Hypertension 47 2006 718 726
31. R.A. Santos, C.H. Castro, and E. Gava Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice Hypertension 47 2006 996 1002
32. S. Epelman, W.H. Tang, S.Y. Chen, F. Van Lente, G.S. Francis, and S. Sen Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin- aldosterone system J Am Coll Cardiol 52 2008 750 754
33. L.S. Zisman, R.S. Keller, and B. Weaver Increased angiotensin-(1-7)- forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2 Circulation 108 2003 1707 1712
34. A.B. Goulter, M.J. Goddard, J.C. Allen, and K.L. Clark ACE2 gene expression is up-regulated in the human failing heart BMC Med 2 2004 19
35. M. Ruiz-Ortega, V. Esteban, and J. Egido The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases Trends Cardiovasc Med 17 2007 19 25
36. D. Chansel, S. Czekalski, S. Vandermeersch, E. Ruffet, M.C. Fournie-Zaluski, and R. Ardaillou Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells Am J Physiol 275 1998 F535 F542
37. P.E. McEwan, G.A. Gray, L. Sherry, D.J. Webb, and C.J. Kenyon Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo Circulation 98 1998 2765 2773
38. M.R. Franz, R. Cima, D. Wang, D. Profitt, and R. Kurz Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias Circulation 86 1992 968 978
39. Z. Wang, L.K. Taylor, W.D. Denney, and D.E. Hansen Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle Circulation 90 1994 2022 2031
40. W.X. Zhu, S.B. Johnson, R. Brandt, J. Burnett, and D.L. Packer Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure J Am Coll Cardiol 30 1997 825 833
41. P. Daleau, and J. Turgeon Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes Pflugers Arch 427 1994 553 555